These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 36455531)
1. Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection. Cho EH Diabetes Metab J; 2022 Nov; 46(6):827-828. PubMed ID: 36455531 [No Abstract] [Full Text] [Related]
2. Biguanide, but not thiazolidinedione, improved insulin resistance in Werner syndrome. Yasuda H; Nagata M; Hara K; Moriyama H; Yokono K J Am Geriatr Soc; 2010 Jan; 58(1):181-2. PubMed ID: 20122053 [No Abstract] [Full Text] [Related]
3. [The effects of thiazolidinedione from the cardiologic viewpoint]. Ziegler R Med Monatsschr Pharm; 2005 Oct; 28(10):365. PubMed ID: 16245456 [No Abstract] [Full Text] [Related]
6. Retrospective review of superficial femoral artery stenting in diabetic patients: thiazolidinedione use may decrease reinterventions. Walker KL; Walsh DB; Goodney PP; Connell SA; Stone DH; Powell RJ; Rzucidlo EM BMC Cardiovasc Disord; 2014 Dec; 14():184. PubMed ID: 25495345 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones: a novel class of drugs for the prevention of diabetic nephropathy? Zheng F; Guan Y Kidney Int; 2007 Dec; 72(11):1301-3. PubMed ID: 18004308 [TBL] [Abstract][Full Text] [Related]
8. New developments in type 2 diabetes mellitus: combination therapy with a thiazolidinedione. Braunstein S Clin Ther; 2003 Jul; 25(7):1895-917. PubMed ID: 12946541 [TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-320a and microRNA-486 predict thiazolidinedione response: Moving towards precision health for diabetes prevention. Flowers E; Aouizerat BE; Abbasi F; Lamendola C; Grove KM; Fukuoka Y; Reaven GM Metabolism; 2015 Sep; 64(9):1051-9. PubMed ID: 26031505 [TBL] [Abstract][Full Text] [Related]
12. The oral insulin sensitizer, thiazolidinedione, increases plasma vascular endothelial growth factor in type 2 diabetic patients. Baba T; Shimada K; Neugebauer S; Yamada D; Hashimoto S; Watanabe T Diabetes Care; 2001 May; 24(5):953-4. PubMed ID: 11347762 [No Abstract] [Full Text] [Related]
13. Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus. Strowig SM; Raskin P Diabetes Obes Metab; 2005 Nov; 7(6):633-41. PubMed ID: 16219007 [TBL] [Abstract][Full Text] [Related]
14. Are thiazolidinediones a preferred drug treatment for type 2 diabetes? Hurren KM; Dunham MW Expert Opin Pharmacother; 2021 Feb; 22(2):131-133. PubMed ID: 33280446 [No Abstract] [Full Text] [Related]
15. Pioglitazone: more than just an insulin sensitizer. Czaja MJ Hepatology; 2009 May; 49(5):1427-30. PubMed ID: 19402055 [No Abstract] [Full Text] [Related]
16. Early combination therapy with a thiazolidinedione for the treatment of type 2 diabetes. Kanzer-Lewis G Diabetes Educ; 2003; 29(6):954-8, 961. PubMed ID: 14692369 [No Abstract] [Full Text] [Related]
17. Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide. Kamm DR; Pyles KD; Sharpe MC; Healy LN; Colca JR; McCommis KS J Biol Chem; 2021; 296():100807. PubMed ID: 34022222 [TBL] [Abstract][Full Text] [Related]
18. [An overweight diabetic does not tolerate metformin. Insulin sensitizer can be prescribed alone, too]. MMW Fortschr Med; 2003 Dec; 145(49):58. PubMed ID: 14963999 [No Abstract] [Full Text] [Related]
19. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects]. Sugiyama Y; Murase K; Ikeda H Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560 [TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes: uses of thiazolidinediones and insulin. Bloomgarden ZT Diabetes Care; 2011 Feb; 34(2):e11-6. PubMed ID: 21270175 [No Abstract] [Full Text] [Related] [Next] [New Search]